Answers are grounded in this paper and cite their sources.
Cross-sectional study reveals antibody presence against influenza A(H3N2) subclade K in Portugal, suggesting vaccination benefits.
The 2025/26 season was marked by co-circulation of influenza A subtypes, with the first detection of A(H3N2) subclade K in September 2025. In August 2025 in Portugal, 14.8% (95% CI: 12.2–17.8) of 886 persons tested had cross-protective antibodies against this subclade. The overall seroprevalence against circulating A(H1N1)pdm09 strains was 28.1% (95% CI: 24.4–32.0). These data highlight the presence of previous cross-reactive antibodies and the possible advantage of vaccination in the extent of detectable antibodies against influenza viruses.
No takes yet. Share an insight, caveat, or question.
Guiomar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: